首页> 外文会议>The Second Asian symposium on pharmaceutical sciences and technology >Enhanced oral bioavailability of ATRA by 2-hydroxypropyl-β-cyclodextrin inclusion complex pellets prepared by fluid-bed coating technique
【24h】

Enhanced oral bioavailability of ATRA by 2-hydroxypropyl-β-cyclodextrin inclusion complex pellets prepared by fluid-bed coating technique

机译:流化床包衣技术制备的2-羟丙基-β-环糊精包合物包合物提高了ATRA的口服生物利用度

获取原文
获取原文并翻译 | 示例

摘要

Purposes: To enhance the oral bioavailability of alltrans-retinoic acid (ATRA) by 2-hydroxypropyl-βcyclodextrin (HPCD) inclusion complex pellets.; Methods: The ATRA/HPCD inclusion complex pellets was prepared with fluid-bed coating technique and characterized in vitro by SEM and dissolution. The oral bioavailability of the ATRA/HPCD inclusion complex pellets was compared with ATRA suspension in beagle dogs with dose of 10 mg/kg.; Results: The resulting pellets were spherical and intact in shape. SEM analysis showed that the pellets were full of crevices on the surface and had a tightly coated inclusion complex layer. In vitro dissolution of ATRA from the inclusion complex pellets was dramatically enhanced as compared with ATRA suspension. Calculated by AUC0-t,the relative bioavailability of the ATRA/HPCD inclusion complex pellets reached 2011.39±1054.64 %. Conclusion: The ATRA/HPCD inclusion complex pellets showed a considerable clinical potential.
机译:目的:通过2-羟丙基-β-环糊精(HPCD)包合物复合物颗粒增强全反式维甲酸(ATRA)的口服生物利用度。方法:采用流化床包衣技术制备ATRA / HPCD包合物,并通过SEM和溶出度进行体外表征。将ATRA / HPCD包合物复合物小丸的口服生物利用度与ATRA悬浮液在剂量为10 mg / kg的比格犬中进行比较。结果:所得粒料为球形,形状完整。 SEM分析表明,颗粒表面充满了缝隙,并具有紧密包被的包合物层。与ATRA悬浮液相比,ATRA从包合物复合物沉淀物中的体外溶出度大大提高。通过AUC0-t计算,ATRA / HPCD包合物的相对生物利用度达到2011.39±1054.64%。结论:ATRA / HPCD包合物复合物小丸显示出相当大的临床潜力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号